Functional Capacity Determinants in Fibromyalgia

NCT ID: NCT07318441

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-15

Study Completion Date

2025-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fibromyalgia is a chronic pain disorder characterized by widespread pain and multiple systemic symptoms that negatively affect functional capacity. Although common symptoms and clinical features of fibromyalgia have been well described, the factors influencing functional capacity remain unclear. Therefore, this study aims to identify the determinants of functional capacity in patients with fibromyalgia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fibromyalgia is a chronic pain disorder characterized by widespread pain, fatigue, sleep disturbances, cognitive problems, and mood disorders, affecting 5% of the population, predominantly women. This condition lacks objective diagnostic markers and relies on subjective symptoms and tender points for diagnosis. The etiology of fibromyalgia, which involves biological, genetic, and environmental factors, remains unclear, making diagnosis difficult due to symptom variability and comorbidities. Pathophysiological mechanisms are not fully understood, leading to difficulties in diagnosis and treatment. Historically, fibromyalgia has evolved from terms such as 'neurasthenia' to 'fibrositis', and understanding has shifted from muscle inflammation to central nervous system dysfunction. The American College of Rheumatology criteria play a crucial role in diagnosing fibromyalgia, helping to reduce patient anxiety and unnecessary testing. In the literature, pain, fatigue, sleep problems, and trigger point sensitivity are among the symptoms frequently seen in fibromyalgia patients. Studies conducted on these symptoms indicate that patients particularly experience anxiety, depression, decreased functional capacity, decreased functional mobility, postural abnormalities, decreased respiratory and peripheral muscle strength, decreased physical activity, and difficulties in daily living activities.

Although surveys conducted with fibromyalgia patients have identified symptoms, no studies have been found that examine the factors affecting functional capacity. Therefore, the aim of this study is to determine the factors affecting functional capacity in patients with fibromyalgia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Individuals diagnosed with fibromyalgia according to the American College of Rheumatology criteria
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fibromyalgia Group

Patients diagnosed with fibromyalgia who attend the Physical Medicine and Rehabilitation Outpatient Clinic will undergo comprehensive assessments of functional capacity, pain, fatigue, mobility, muscle strength, posture, psychosocial factors, physical activity level, circadian rhythm, and sleep quality. No intervention will be applied.

Group Type OTHER

Assessment Only

Intervention Type OTHER

No therapeutic intervention will be applied. Participants will undergo standardized clinical, functional, and self-reported assessments, including functional capacity tests, pain and fatigue evaluation, mobility and muscle strength assessments, posture analysis, psychosocial questionnaires, physical activity level, circadian rhythm, and sleep quality evaluation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment Only

No therapeutic intervention will be applied. Participants will undergo standardized clinical, functional, and self-reported assessments, including functional capacity tests, pain and fatigue evaluation, mobility and muscle strength assessments, posture analysis, psychosocial questionnaires, physical activity level, circadian rhythm, and sleep quality evaluation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals diagnosed with fibromyalgia according to the American College of Rheumatology criteria
* Be 18 years of age or older
* Be a volunteer
* Be able to read and write

Exclusion Criteria

* Having a condition that prevents communication,
* Having undergone surgery within the last 6 months
* Being an elite athlete
* Having an active infection
* Having a neurological or orthopedic problem that prevents movement
* Being a cancer patient
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Democracy University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Betül Taşpınar

Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Beyzanur Beğenen Şavlı, Msc.Pt.

Role: PRINCIPAL_INVESTIGATOR

Izmir Democracy University

Betül Taspinar, Prof.Dr.

Role: PRINCIPAL_INVESTIGATOR

Izmir Democracy University

Ferruh Taspinar, Prof.Dr.

Role: PRINCIPAL_INVESTIGATOR

Izmir Democracy University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Betül TAŞPINAR

Konak, İ̇zmi̇r, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FMS-35

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fibromyalgia Syndrome and Chronic Pelvic Pain
NCT07344675 ENROLLING_BY_INVITATION
Fibromyalgia, Cognitive Rehabilitation Software
NCT07010172 NOT_YET_RECRUITING NA